about
Long-term survival in a patient with glioblastoma on antipsychotic therapy for schizophrenia: a case report and literature reviewPREX1 integrates G protein-coupled receptor and phosphoinositide 3-kinase signaling to promote glioblastoma invasion.Anti-cancer effects of dopamine in human glioma: involvement of mitochondrial apoptotic and anti-inflammatory pathways.A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma.Drug Repositioning in Glioblastoma: A Pathway Perspective.Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players.
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Dopamine signaling: target in glioblastoma.
@en
Dopamine signaling: target in glioblastoma.
@nl
type
label
Dopamine signaling: target in glioblastoma.
@en
Dopamine signaling: target in glioblastoma.
@nl
prefLabel
Dopamine signaling: target in glioblastoma.
@en
Dopamine signaling: target in glioblastoma.
@nl
P2860
P356
P1433
P1476
Dopamine signaling: target in glioblastoma.
@en
P2093
Zdenek Hodny
P2860
P304
P356
10.18632/ONCOTARGET.1835
P407
P50
P577
2014-03-01T00:00:00Z